Sugimoto, Yoichiro
Ratcliffe, Peter J. http://orcid.org/0000-0002-2853-806X
Funding for this research was provided by:
Cancer Research UK (CC2092)
RCUK | Medical Research Council (CC2092)
Wellcome Trust (CC2092)
Ludwig Institute for Cancer Research
Wellcome Trust (106241/Z/14/Z)
Article History
Received: 6 July 2021
Accepted: 15 July 2022
First Online: 12 September 2022
Competing interests
: P. J. R. is a scientific co-founder and equity holder in ReOx Ltd. He is a non-executive director of Immunocore Ltd and holds a consultancy with IDP Discovery Pharma SL. Y. S. declares no competing interests.